Adriamycin Alters Glomerular Endothelium to Induce Proteinuria
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The pathophysiology underlying the nephrotic syndrome is becoming clear for several inherited podocytopathies; the mechanisms of injury that lead to the acquired forms of this disease are not well understood. We explored these mechanisms using the mouse model of adriamycin-induced proteinuria. We estimated the fractional clearances for FITC-Ficolls, albumin, and neutral albumin in cooled, isolated, perfused kidneys (cIPK) in situ. Treatment with adriamycin led to a significant increase in the fractional clearance of albumin and of Ficoll with radii larger than 20 A[Combining Ring Above]. Neutral albumin (33.4 A[Combining Ring Above]) and similarly sized Ficoll behaved similarly to each other. In addition, adriamycin led to a significant loss of charge density and size selectivity of the glomerular barrier. The thickness of the glomerular endothelial surface layer (i.e., or the glycocalyx) in adriamycin-treated animals was only 20% of that in normal animals. Finally, several proteoglycans were downregulated in isolated glomeruli. In summary, adriamycin thins the glomerular glycocalyx, perhaps by downregulating proteoglycan synthesis, and alters glomerular charge- and size selectivity. These data suggest that the glomerular endothelium may play a role in the pathogenesis of proteinuric renal diseases. Nephrotic syndromes are important and dramatic clinical conditions in which the underlying mechanisms are poorly understood and the treatment is unspecific and often ineffective.1 The evidence for a highly size- and charge-selective glomerular barrier is overwhelming,2 but there are alternative views3 as is elaborated in a recent review.1 The glomerular barrier consists of a fenestrated endothelium covered with a surface layer, the glomerular basement membrane (GBM), and podocyte foot processes.1 Recent advances concerning podocyte biology4,5 have revealed the molecular mechanism behind several genetic disorders,6 but less is known about the acquired diseases.7 Studies on laminin-deficient mice suggest that the changes in the GBM may precede those in the podocyte.8 Furthermore, the glomerular endothelial surface layer (ESL) may offer significant restriction to macromolecules.9,10,7,11–13 Thus, proteinuria is likely to occur after damage to any one of the components of the glomerular barrier.1 The study presented here was undertaken to further explore the intricate mechanisms underlying nephrotic syndrome. As an experimental model, we chose adriamycin, which induces proteinuria in mice.14–16 The glomerular damage was estimated using functional, morphologic, and molecular techniques. In vivo studies of proteinuria in patients or animals have the major disadvantage that proteins can be reabsorbed, secreted, or degraded in the tubules. Consequently, the protein concentration in final urine may differ considerably from that of primary urine. To overcome these limitations, one may use the inert polysaccharides dextran or Ficoll as markers instead of albumin. A few years ago, we published the first analysis of glomerular size and charge selectivity in mice using albumin and Ficoll.13 In the study presented here, we extend this analysis using charge-modified neutral albumin as well. Electron microscopy was used to measure the thickness of the glomerular ESL.11 Moreover, gene and protein expressions of several proteoglycans and glycosaminoglycan (GAG) synthesis enzymes were analyzed with techniques established in the lab.10,12,17 RESULTS Mice with the high dose of adriamycin (AD mice, 25 mg/kg) had a significant weight-loss from day 3 and onward whereas there was no difference between controls and low-dose adriamycin mice (ADL mice, 10 mg/kg) (Figure 1). The albumin/creatinine ratio measured in vivo at day 6 from spot urine was significantly increased from 0.10 (SEM + 0.022, −0.018) in controls to 0.67 (+0.272, −0.194) in AD mice (P < 0.001). There was no significant increase for ADL mice, 0.16 (+0.030, −0.025). Functional Properties of the Glomerular Barrier The fractional clearances for all Ficoll sizes, 12 to 70 A[Combining Ring Above], are shown in Figure 2. There was a significantly increased fractional clearance of Ficoll in AD mice compared with controls and ADL mice, at least for Stokes-Einstein radii (aSE) exceeding 20 A[Combining Ring Above] (P < 0.01, Figure 2). Because there was no difference between controls and ADL mice, further analyses were done for controls and AD mice only. The GFRs were similar for controls and AD mice as shown in Table 2. The fractional clearance for albumin (HSA) was significantly increased from 0.0042 (+0.0008, −0.0007) in controls to 0.0150 (+0.0047, −0.0036) in the AD group (P < 0.01, Figure 3). Neutral Ficoll of similar size as albumin (aSE 35.5 A[Combining Ring Above]) had a fractional clearance of 0.089 (±0.0042) in controls and was significantly increased to 0.107 (±0.010) in AD mice (P < 0.01, Figure 3). Neutral HSA (nHSA, aSE 33.4 A[Combining Ring Above]) had a fractional cl
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Method for the Quantitative Modification and Estimation of Carboxylic Acid Groups in Proteins
Hoare, D. G., & Koshland, D. E. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)95981-8 · Cited by 934
Properties of the Glomerular Barrier and Mechanisms of Proteinuria
Haraldsson, B., Nyström, J., & Deen, W. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00055.2006 · Cited by 909 · cited 3×
“Mean SEM for mRNA expression relative to housekeeping genes and controls (1) for the small leucine rich proteoglycans biglycan, decorin, and fibromodulin.”
BackgroundSelf-citationNephrin is specifically located at the slit diaphragm of glomerular podocytes
Ruotsalainen, V., Ljungberg, P., Wartiovaara, J., Lenkkeri, U., Kestilä, M., Jalanko, H., Holmberg, C., & Tryggvason, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7962 · Cited by 767
Vink, H., & Duling, B. R. (1996) · Circulation Research · doi:10.1161/01.res.79.3.581 · Cited by 615
Hereditary Proteinuria Syndromes and Mechanisms of Proteinuria
Tryggvason, K., Patrakka, J., & Wartiovaara, J. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052131 · Cited by 576
Venturoli, D., & Rippe, B. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00171.2004 · Cited by 461
Russo, L. M., Sandoval, R. M., McKee, M., Osicka, T. M., Collins, A. B., Brown, D., Molitoris, B. A., & Comper, W. D. (2007) · Kidney International · doi:10.1038/sj.ki.5002041 · Cited by 400
Podocin Localizes in the Kidney to the Slit Diaphragm Area
Roselli, S., Gribouval, O., Boute, N., Sich, M., Benessy, F., Attié, T., Gubler, M.-C., & Antignac, C. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64357-x · Cited by 341
Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events
Wang, Y., Wang, Y. P., Tay, Y.-C., & Harris, D. C. H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00342.x · Cited by 326
Jarad, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28414 · Cited by 230
Cited by
Adriamycin nephropathy: A model of focal segmental glomerulosclerosis
LEE, V. W., & HARRIS, D. C. (2011) · Nephrology · doi:10.1111/j.1440-1797.2010.01383.x · Cited by 433
The cell biology of renal filtration
Scott, R. P., & Quaggin, S. E. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201410017 · Cited by 372
Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability
Salmon, A. H., & Satchell, S. C. (2012) · The Journal of Pathology · doi:10.1002/path.3964 · Cited by 315
Daehn, I., Casalena, G., Zhang, T., Shi, S., Fenninger, F., Barasch, N., Yu, L., D’Agati, V., Schlondorff, D., Kriz, W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71195 · Cited by 294
Self-citationLoss of the Endothelial Glycocalyx Links Albuminuria and Vascular Dysfunction
Salmon, A. H. J., Ferguson, J. K., Burford, J. L., Gevorgyan, H., Nakano, D., Harper, S. J., Bates, D. O., & Peti-Peterdi, J. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010017 · Cited by 267
New insights into the role of podocytes in proteinuria
Patrakka, J., & Tryggvason, K. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.108 · Cited by 185
Hara, S., Kobayashi, N., Sakamoto, K., Ueno, T., Manabe, S., Takashima, Y., Hamada, J., Pastan, I., Fukamizu, A., Matsusaka, T., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.04.007 · Cited by 48
Metadata
- Authors
- Jeansson, M., Bjo[Combining Diaeresis]rck, K., Tenstad, O., & Haraldsson, B. D.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2009-01
- Volume
- 20
- Issue
- 1
- Pages
- 114-122
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2168171496
- Cited by
- 175
- References
- 21
- FWCI
- 5.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.